Reports and Briefs on Pharmaceuticals

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Amylin Acquisition Rumors

Analysis of Bristol-Myers Squibb's rumored bid to acquire Amylin Pharmaceuticals and which other companies may be interested in acquiring the company following its apparent rejection of Bristol-Myers Squibb's offer.

Published By Datamonitor
30 Mar 2012 $1520
Buy
Report
Report

Amylin Pharmaceuticals, Inc.: PharmaVitae Report

This report analyzes Amylin's corporate strategy, sales outlook and financial position through to 2016, supported by in-depth analysis of the company’s key products, driven by patient-based forecasts and key opinion leader interviews.

Published By Datamonitor
20 Feb 2012 $2800
Buy
Report
Report

Apotex Inc.: PharmaVitae Report

Analysis of Apotex's corporate strategy, marketed portfolio and pipeline potential over 2010-2016.

Published By Datamonitor
21 Dec 2011 $2800
Buy
Report
Report

Ariad Pharmaceuticals: PharmaVitae Report

Analysis of Ariad Pharmaceuticals' corporate history, corporate relationships, prospects to the end of the forecast period, and Datamonitor's evaluation of the company's strategy and key strengths, weaknesses, opportunities and threats.

Published By Datamonitor
06 Jun 2012 $2800
Buy
Report
Report

Astellas Pharma Inc.: PharmaVitae Report

Analysis of Astellas's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
02 Sep 2011 $2800
Buy
Report
Report

AstraZeneca plc: Company Analysis

Analysis of AstraZeneca's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and 2017

Published By Datamonitor
27 Sep 2012 $2800
Buy
Report
Report

Aveo Pharmaceuticals, Inc.: PharmaVitae Report

Analysis of Aveo's corporate history, corporate relationships, prospects to the end of the forecast period, and Datamonitor's evaluation of the company's strategy and key strengths, weaknesses, opportunities and threats.

Published By Datamonitor
27 Jul 2012 $2800
Buy
Report
Report

Baxter International Inc.: PharmaVitae Report

Analysis of Baxter's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
14 Dec 2011 $2800
Buy
Report
Report

Bayer AG: Company Analysis

Analysis of Bayer's corporate strategy, marketed portfolio, pipeline potential and financial position in 2011 and to 2017

Published By Datamonitor
08 Aug 2012 $2800
Buy
Report
Report

Big Multinational Pharma in China

After enjoying 2 decades of fast growth and expansion, big multinational pharma has started to rethink and reformulate strategies for China.

Published By Datamonitor
08 Jan 2013 $2000
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.